<VariationArchive VariationID="487687" VariationName="NM_138459.5(NUS1):c.128_141dup (p.Val48fs)" VariationType="Duplication" Accession="VCV000487687" Version="28" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-23" DateCreated="2018-01-26" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="480769" VariationID="487687">
      <GeneList>
        <Gene Symbol="NUS1" FullName="NUS1 dehydrodolichyl diphosphate synthase subunit" GeneID="116150" HGNC_ID="HGNC:21042" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="117675469" stop="117710727" display_start="117675469" display_stop="117710727" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="117996616" stop="118031889" display_start="117996616" display_stop="118031889" Strand="+" />
          </Location>
          <OMIM>610463</OMIM>
          <Haploinsufficiency last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NUS1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-09-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NUS1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_138459.5(NUS1):c.128_141dup (p.Val48fs)</Name>
      <CanonicalSPDI>NC_000006.12:117675789:CTGCCGCGCCGCCTCTGCCGCG:CTGCCGCGCCGCCTCTGCCGCGCCGCCTCTGCCGCG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="117675789" stop="117675790" display_start="117675789" display_stop="117675790" variantLength="14" positionVCF="117675789" referenceAlleleVCF="G" alternateAlleleVCF="GCTGCCGCGCCGCCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="117996952" stop="117996953" display_start="117996952" display_stop="117996953" variantLength="14" positionVCF="117996952" referenceAlleleVCF="G" alternateAlleleVCF="GCTGCCGCGCCGCCT" />
      </Location>
      <ProteinChange>V48fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.117996961_117996974dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.117996961_117996974dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.117675798_117675811dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.117675798_117675811dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_054913.1" sequenceAccession="NG_054913" sequenceVersion="1" change="g.5345_5358dup">
            <Expression>NG_054913.1:g.5345_5358dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138459.5" sequenceAccession="NM_138459" sequenceVersion="5" change="c.128_141dup" MANESelect="true">
            <Expression>NM_138459.5:c.128_141dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_612468.1" sequenceAccession="NP_612468" sequenceVersion="1" change="p.Val48fs">
            <Expression>NP_612468.1:p.Val48fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658657609" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610463.0003" DB="OMIM" />
        <XRef Type="rs" ID="1554200722" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_138459.5(NUS1):c.128_141dup (p.Val48fs) AND Intellectual disability, autosomal dominant 55, with seizures" Accession="RCV000577867" Version="5">
        <ClassifiedConditionList TraitSetID="40073">
          <ClassifiedCondition DB="MedGen" ID="C4693371">Intellectual disability, autosomal dominant 55, with seizures</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_138459.5(NUS1):c.128_141dup (p.Val48fs) AND not provided" Accession="RCV001090683" Version="19">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-01-26" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25066056</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29100083</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31656175</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32485575</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40073" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38512" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 55, with seizures</ElementValue>
                <XRef ID="MONDO:0030921" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES</ElementValue>
                <XRef Type="MIM" ID="617831" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610463.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES</ElementValue>
                <XRef Type="MIM" ID="617831" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRD55</ElementValue>
                <XRef Type="MIM" ID="617831" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16260" />
                <XRef ID="16260" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4693371" DB="MedGen" />
              <XRef ID="MONDO:0030921" DB="MONDO" />
              <XRef Type="MIM" ID="617831" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1332242" SubmissionDate="2021-10-20" DateLastUpdated="2021-10-25" DateCreated="2018-01-26">
        <ClinVarSubmissionID localKey="610463.0003_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES" title="NUS1, 14-BP DUP, NT128_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES" />
        <ClinVarAccession Accession="SCV000679675" DateUpdated="2021-10-25" DateCreated="2018-01-26" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 15-year-old boy (HSJ0623) with autosomal dominant intellectual developmental disorder-55 with seizures (MRD55; 617831), Hamdan et al. (2017) identified a de novo heterozygous 14-bp duplication (c.128_141dup, NM_138459.4) in the NUS1 gene, predicted to result in a frameshift and premature termination (Val48ProfsTer7) in transmembrane 2. The mutation, which was found by whole-genome sequencing and confirmed by Sanger sequencing, was filtered against public databases, including the 1000 Genomes Project, Exome Variant Server, and ExAC. Functional studies of the variant and studies of patient cells were not performed, but the mutation was predicted to result in haploinsufficiency.</Attribute>
              <Citation>
                <ID Source="PubMed">29100083</ID>
              </Citation>
              <XRef DB="OMIM" ID="617831" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NUS1" />
          </GeneList>
          <Name>NUS1, 14-BP DUP, NT128</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">14-BP DUP, NT128</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610463.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2467952" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="102421|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246360" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NUS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="GCTGCCGCGCCGCCT" referenceAllele="G" start="117996952" stop="117996952" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5413381" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_138459_4_NUS1_c_128_141dupCCGCCTCTGCCGCG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002769095" DateUpdated="2024-07-23" DateCreated="2022-12-24" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25066056</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29100083</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31656175</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32485575</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with autosomal recessive congenital disorder of glycosylation, type 1aa (MIM#617082) and autosomal dominant intellectual disability, 55, with seziures (MIM#617831). (I) 0107 - This gene is associated with autosomal dominant disease. A single homozygous missense variant has been reported to cause recessive disease (OMIM, PMID: 25066056), whereas all other variants have been reported in association with the dominant condition (PMIDs: 29100083, 31656175, 32485575). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0702 - Other NMD predicted variants comparable to the one identified in this case have strong previous evidence for pathogenicity (DECIPHER). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been observed in two individuals with NUS1-related conditions, including one de novo report (ClinVar, PMID: 29100083). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NUS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13001</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_138459.4:c.128_141dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617831" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1332242" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES" MappingRef="Preferred">
        <MedGen CUI="C4693371" Name="Intellectual disability, autosomal dominant 55, with seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5413381" TraitType="Disease" MappingType="XRef" MappingValue="617831" MappingRef="OMIM">
        <MedGen CUI="C4693371" Name="Intellectual disability, autosomal dominant 55, with seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467952" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

